HOME >> BIOLOGY >> NEWS
Tumor Oxygen Level And Blood Flow Fluctuate, Duke Scientists Discover

PHILADELPHIA -- In a discovery that might help explain why widely used cancer therapies are less than optimal, Duke University Medical Center researchers have found that a tumor's oxygen level and blood flow can fluctuate rapidly. The Duke animal study, which contradicts previous assumptions about tumors, could be important because the two major cancer treatments, radiation and chemotherapy, depend on a constant high oxygen level and steady blood flow within a tumor, scientists said. "These fluctuations in oxygen level and blood flow are not predictable and might represent an impediment to radiation therapy and drug therapy," said Mark Dewhirst, co-director of the radiation oncology and hyperthermia program at Duke Comprehensive Cancer Center and associate professor of pathology. "Before this work, there was no way to reliably measure these values."

Dewhirst prepared the findings for presentation Tuesday at an American Association for Cancer Research meeting. His study, which was done in collaboration with Rod Braun, assistant professor in radiation oncology, was funded by the National Cancer Institute. A report based on the results of this study has been accepted for publication by the American Journal of Physiology. High oxygen levels are crucial for effective radiation therapy, Dewhirst explained, because radiation kills tumor cells by forming oxygen radicals -- highly reactive oxygen atoms that damage DNA.

Chemotherapy might be affected by the fluctuations, Dewhirst said, because if tumor blood flow drops, the drugs might not be delivered efficiently throughout the tumor.

While low oxygen levels, called hypoxia, are known to exist in certain tumors, researchers had not measured changes in oxygen levels over time. In the current study, Dewhirst and his colleagues measured oxygen levels in mammary tumors in seven rats using an electrochemical probe that produces an electrical current depending on the amount of oxygen present in the tissue.

T
'"/>

Contact: Joanna Downer
downe010@mc.duke.edu
919-684-4148
Duke University Medical Center
14-Apr-1999


Page: 1 2 3

Related biology news :

1. Tumor cell-specific therapy shows preclinical promise
2. Tumor cells made more sensitive to radiation by blocking a key cellular molecule
3. Discovery Of 13 Genes Expressed In Brain Tumors May Lead To More Effective Diagnosis Or Prevention
4. Dietary Lutein Inhibits Mammary Tumor Growth And Normalizes Immune Balance In Tumor-Bearing Mice
5. Vion Demonstrates Readiness Of First Tumor-Targeting Salmonella For Human Testing Against Solid Tumors
6. Compounds From Fruits, Vegetables And Grains Slow The Growth Of Human Tumor Cells
7. New Cell Isolation Method Will Aid In Studying Tumor Development
8. Wistar Institute To Host 3rd International Conference On Molecular And Clinical Genetics Of Childhood Renal Tumors And The Mitchell Ross Symposium
9. Scientists Study Proteins Role In Tumor Development In Fish
10. Fly Tumor Points Way To New Understanding Of Cancer Development
11. Vions TAPET Organisms Demonstrate Reduced Virulence, Increased Safety While Retaining Ability To Specifically Target Tumors

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/30/2017)... , March 30, 2017 Trends, opportunities ... (physiological and behavioral), by technology (fingerprint, AFIS, iris recognition, ... recognition, and others), by end use industry (government and ... immigration, financial and banking, and others), and by region ... , Asia Pacific , and ...
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
(Date:3/24/2017)... March 24, 2017 The Controller General of Immigration ... Abdulla Algeen have received the prestigious international IAIR Award for ... Continue Reading ... ... Deputy Controller Abdulla Algeen (small picture on the right) have received the ...
Breaking Biology News(10 mins):
(Date:10/9/2017)... 9, 2017  BioTech Holdings announced today identification ... its ProCell stem cell therapy prevents limb loss ... Company, demonstrated that treatment with ProCell resulted in ... as compared to standard bone marrow stem cell ... in reduction of therapeutic effect.  ...
(Date:10/9/2017)... ... October 09, 2017 , ... ... line of medical marijuana products targeting the needs of consumers who are incorporating ... Kindred takes place in Phoenix, Arizona. , As operators of two successful Valley ...
(Date:10/7/2017)... Seattle, WA (PRWEB) , ... ... ... the industry leader in Hi-C-based genomic technologies, launched its ProxiMeta™ Hi-C metagenome ... the ProxiMeta Hi-C kit and accompanying cloud-based bioinformatics software to perform Hi-C ...
(Date:10/6/2017)... (PRWEB) , ... October 06, 2017 , ... ... host a lunch discussion and webinar on INSIGhT, the first-ever adaptive clinical trial ... Investigator, Dana-Farber Cancer Institute. The event is free and open to the public, ...
Breaking Biology Technology:
Cached News: